# Development of Digital Biomarkers in Multiple Sclerosis: Validation Study 2

> **NCT06309173** · — · WITHDRAWN · sponsor: **Research Center for Clinical Neuroimmunology and Neuroscience Basel**

## Conditions studied

- Multiple Sclerosis

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06309173
- **Lead sponsor:** Research Center for Clinical Neuroimmunology and Neuroscience Basel
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** WITHDRAWN
- **Start date:** 2026-05
- **Primary completion:** 2029-12
- **Final completion:** 2029-12
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** The study was terminated prior to first patient enrollment based on strategic considerations.
- **Last updated:** 2026-04-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06309173

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06309173, "Development of Digital Biomarkers in Multiple Sclerosis: Validation Study 2". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT06309173. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*